Thousands of investors, millions in profit
Results 1 - 10 of 719 : 1 2 3 4 5 6 7 8 9 Next
Astex's Dacogen as a treatment for AML hits a roadblock.
Promising companies from investors that already beat the market with huge gains
1 Cheap Biotech Small-Cap With Huge Potential
Several big-name partnerships and a lot of cash make this one attractive company.
19 Clinical Trials Aren't Enough
The FDA rejects Bristol-Myers and AstraZeneca's dapagliflozin.
Here's what the new year has in store for Merck.
M&A expectations will do that.
Exelixis 2011: Not What the Doctor Ordered
A tale of an inability to get a Special Protocol Assessment from the FDA.
5 of Last Week's Biggest Losers
These five stocks only made shorts some serious money last week.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK